SCHEMBL7868441

SCHEMBL7868441

COc1ccc(C(=O)N2CC(CN3CCC(c4ccccc4)CC3)C(c3ccsc3)C2)cc1

nearest known ligand 0.68

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 18/20 0.68
HSD11B1 P28845 1/20 0.54
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870899 0.91 CCR5 (0.56) CCR5HSD11B1ALDH1A1LMNA
SCHEMBL7869795 0.91 CCR5 (0.80) CCR5
SCHEMBL7825792 0.91 CCR5 (0.80) CCR5HSD11B1
SCHEMBL7871872 0.90 CCR5 (0.70) CCR5
SCHEMBL7875110 0.88 CCR5 (0.82) CCR5
SCHEMBL7868433 0.85 CCR5 (0.68) CCR5ALDH1A1
SCHEMBL7871174 0.85 CCR5 (0.65) CCR5
SCHEMBL7869940 0.85 CCR5 (0.70) CCR5
SCHEMBL7863129 0.84 CCR5 (0.66) CCR5
SCHEMBL7871867 0.84 CCR5 (0.64) CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US claimed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed